TORONTO, ONTARIO / ACCESSWIRE / CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") a global medical provider of electrocardiogram ("ECG") acquisition and management ...
LOS ANGELES, CA - December 10, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) ...
The FDA has granted 510(k) clearance to Biofourmis’ RhythmAnalytics, a cloud-based software product that uses deep learning to read and interpret cardiac arrhythmias. According to a statement from the ...
BELLEVUE, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc. (“Cardiac Insight” or the “Company) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that ...
SANTA CLARA, Calif. – HeartBeam, Inc. (NASDAQ: BEAT), a pioneer in cardiac care technology with a market capitalization of $65.76 million, has announced positive results from its VALID-ECG pivotal ...
BELLEVUE, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc., a healthcare innovator specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis software that delivers highly ...
Wearable data is becoming more integrated into clinical practice, but there is one caveat, explains Sense2beat CEO Natalia Glazkova — those devices can be contaminated by a glut of data. Sense2beat is ...
Apple’s latest smartwatch can now detect signs of a deadly heart condition – potentially saving lives across the UK. But Dr Helen Tyrer, a senior clinical research fellow at Imperial College London, ...
HeartBeam (NASDAQ: BEAT) announced it has completed patient enrollment ahead of schedule in its ALIGN-ACS pilot study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results